secwatch.observer — SEC 8-K summary
======================================

Issuer:     ProMIS Neurosciences Inc. (PMN)
CIK:        0001374339
Form:       8-K
Filed at:   2026-05-20T20:30:26+00:00
Accession:  0001104659-26-064545
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shareholders approve increase in stock option plan shares by 900,000 at 2026 annual meeting
--------------------------------------------------------------------------------

- All 7 director nominees elected; broker non-votes of 614,643.
- Ratification of Baker Tilly as auditor approved: 4,657,634 for, 4,415 against.
- Amendment to 2025 Plan increases shares available to 1,017,868 from 117,868.
- Shareholders representing 53.1% of outstanding common shares present at meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1374339/000110465926064545/0001104659-26-064545-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1374339/000110465926064545/pmn-20260520x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-064545

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer